Gm1-gangliosidosis, Type I
Description
GM1-Gangliosidosis is an autosomal recessive lysosomal storage disease characterized by accumulation of ganglioside substrates in lysosomes. Clinically, patients show variable degrees of neurodegeneration and skeletal abnormalities. There are 3 main clinical variants categorized by severity and variable residual beta-galactosidase activity. Type I, or infantile form, shows rapid psychomotor deterioration beginning within 6 months of birth, generalized central nervous system involvement, hepatosplenomegaly, facial dysmorphism, macular cherry-red spots, skeletal dysplasia, and early death. Type II, or late-infantile/juvenile form (OMIM ), has onset between 7 months and 3 years, shows generalized central nervous system involvement with psychomotor deterioration, seizures, localized skeletal involvement, and survival into childhood. Hepatosplenomegaly and cherry-red spots are usually not present. Type III, or adult/chronic form (OMIM ), shows onset from 3 to 30 years and is characterized by localized skeletal involvement and localized central nervous system involvement, such as dystonia or gait or speech disturbance. There is an inverse correlation between disease severity and residual enzyme activity (Suzuki et al., 2001).See also Morquio B disease (OMIM ), an allelic disorder with skeletal anomalies and no neurologic involvement.The GM2-gangliosidoses include Tay-Sachs disease (OMIM ) and Sandhoff disease (OMIM ).
Clinical Features
Top most frequent phenotypes and symptoms related to Gm1-gangliosidosis, Type I
- Intellectual disability
- Seizures
- Global developmental delay
- Short stature
- Scoliosis
- Ataxia
- Hypertelorism
- Nystagmus
- Strabismus
- Muscle weakness
And another 73 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Based on the latest data available GM1-GANGLIOSIDOSIS, TYPE I have a estimated birth prevalence of 0.75 per 100k worldwide.— No data available about the known clinical features onset.
Alternative names
Gm1-gangliosidosis, Type I Is also known as gangliosidosis, generalized gm1, type 1, gangliosidosis, generalized gm1, type i, glb1 deficiency, gangliosidosis, generalized gm1, infantile form, beta-galactosidase-1 deficiency.
Researches and researchers
Doctors, researchs, and experts related to Gm1-gangliosidosis, Type I extracted from public data.
Gm1-gangliosidosis, Type I Experts map
Current Researchs and researchers
-
TORONTO — Dr Don J MAHURAN
Investigator of research project
-
Institution/s:
— Hospital for Sick Children, Research Institute -
Research area/topic::
Enzyme Enhancement Therapy for GM1 Gangliosidosis
-
Institution/s:
-
LYON — Dr Marie-Thérèse VANIER
Coordinator of research network
-
Institution/s:
— INSERM U 820, Faculté de médecine - RTH Laënnec -
Research area/topic::
Réseau sur les maladies de surcharge lysosomales
-
Institution/s:
Gm1-gangliosidosis, Type I Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
MitoMet®Plus aCGH Analysis.
By Baylor Miraca Genetics Laboratories (United States).
RGS9, RHO, GRK1, RLBP1, RNASEL, BCS1L, RP1, RP2, RP9, RPE65, RPGR, RPL35A, MRPL3, RPS14, RS1, SAG, SARDH, SCO2, SCP2, SDHB , (...)
View the complete list with 612 more genes
Specificity
1 %
Genes
100 % |
GeneAware Complete Panel Version 2 (Female).
By Baylor Miraca Genetics Laboratories (United States).
RMRP, BCS1L, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC26A2, SLC35A3, SLC7A7, SMN1, SMPD1, BTD, BTK , (...)
View the complete list with 139 more genes
Specificity
1 %
Genes
100 % |
GeneAware Complete Panel Version 2 (Male).
By Baylor Miraca Genetics Laboratories (United States).
RMRP, BCS1L, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC26A2, SLC35A3, SLC7A7, SMN1, SMPD1, BTD, TGM1 , (...)
View the complete list with 129 more genes
Specificity
1 %
Genes
100 % |
Non-immune Hydrops Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RIT1, RPL11, RPL35A, RPL5, RPS10, RPS17, RPS19, RPS24, RPS26, SEC23B, SLC17A5, BRAF, SMPD1, SOS1, SOS2, SOX18, UROS, CBL, SHOC2, ALG9 , (...)
View the complete list with 66 more genes
Specificity
2 %
Genes
100 % |
Lysosomal Storage Disease Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
SGSH, SLC17A5, SMPD1, TCF4, MCOLN1, NPC2, ADAMTSL2, DNAJC5, SUMF1, TPP1, CLN3, CLN5, CLN6, CLN8, DYM, ANTXR2, COL11A2, PEX26, GNE, CTNS , (...)
View the complete list with 54 more genes
Specificity
2 %
Genes
100 % |
GM1 gangliosidosis.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
GLB1
Specificity
100 %
Genes
100 % |
Morquio Syndrome B.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
GLB1
Specificity
100 %
Genes
100 % |
Dystonia Exome Panel.
By Genetic Services Laboratory University of Chicago (United States).
BCS1L, SCN8A, SCP2, SDHA, SGCE, SLC16A2, SLC20A2, SLC2A1, SLC6A3, SLC6A8, SPR, SQSTM1, STXBP1, SUCLA2, SUOX, SURF1, SYNJ1, TAF1, TBCD, TH , (...)
View the complete list with 150 more genes
Specificity
1 %
Genes
100 % |
You can get up to 98 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET OMIM Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50 EHLERS-DANLOS SYNDROME WITH SHORT STATURE AND LIMB ANOMALIES; EDSSLA LACTATE DEHYDROGENASE B DEFICIENCY; LDHBD